All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza A-31356626
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 31356626 H275Y
NA
NA
Influenza A
Influenza B
D
G
R
C
L
View
2 31356626 I222V
NA
NA
Influenza A
Influenza B
G
R
C
L
View
3 31356626 H311Q
HA1
HA
Influenza A
Influenza B
G
R
C
L
View
4 31356626 E62G
HA
HA
Influenza A
Influenza B
G
R
C
L
View
5 31356626 K160T
HA
HA
Influenza A
Influenza B
G
R
I
C
L
View
6 31356626 K92R
HA
HA
Influenza A
Influenza B
G
R
C
L
View
7 31356626 N121K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
8 31356626 P194L
HA
HA
Influenza A
Influenza B
G
R
I
C
L
View
9 31356626 R142G
HA
HA
Influenza A
Influenza B
G
R
C
L
View
10 31356626 R142K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
11 31356626 R261Q
HA
HA
Influenza A
Influenza B
G
R
C
L
View
12 31356626 S144K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
13 31356626 T131K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
14 31356626 T135K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
15 31356626 T135N
HA
HA
Influenza A
Influenza B
G
R
C
L
View
16 31356626 T160K
HA
HA
Influenza A
Influenza B
G
R
C
L
View
17 31356626 D222G
HA
HA
Influenza A
Influenza B
G
R
C
L
View
18 31356626 D222N
HA
HA
Influenza A
Influenza B
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.